SAFETY AND EFFICACY OF ULTRASE MT12 TO PLACEBO IN TREATMENT OF STEATORRHEA

ULTRASE MT12 作为安慰剂治疗脂肪泻的安全性和有效性

• 批准号: 6121387
• 负责人: CHRISTOPHER P DUGGAN
• 金额: $ 5.27万
• 依托单位: BRIGHAM AND WOMEN'S HOSPITAL
• 依托单位国家: 美国
• 财政年份: 1998
• 资助国家: 美国
• 起止时间: 1998-12-01 至 1999-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6121387
• 关键词: child (0-11); clinical research; clinical trial phase I; cystic fibrosis; drug screening /evaluation; enzyme deficiency; human subject; human therapy evaluation; lipase; metabolism disorder chemotherapy; pancreas enzyme; pediatric pharmacology; steatorrhea

The purpose of this study is to determine whether a drug called Ultrase MT 12 is effective and safe in the treatment of pancreatic enzyme insufficiency in patients with cystic fibrosis.

本研究的目的是确定一种名为Ultrase MT 12的药物在治疗囊性纤维化患者的胰腺酶功能不全方面是否有效和安全。